Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Uyttenhove, Catherine, Pilotte, Luc, Théate, Ivan, Stroobant, Vincent, Colau, Didier, Parmentier, Nicolas, Boon, Thierry, Van den Eynde, Benoît J·2003·Nature Medicine

DOI 10.1038/nm934

Cited by (1,003)

Items 401–500 of 1,003

How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
Alessandro Delli Poggi, Serena Varesano, Maria Raffaella Zocchi · 2018 · Frontiers in Immunology
Microbiota and cancer: host cellular mechanisms activated by gut microbial metabolites
Sofia A. Tsvetikova, Elena I. Koshel · 2020 · International Journal of Medical Microbiology
Tumor-Infiltrating Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Patients with Breast Carcinoma
Helena Hornychová, Bohuslav Melichar, M Tomšová, Jindřiška Mergancová, Hana Urminská, Aleš Ryška · 2008 · Cancer Investigation
Immune escape mechanisms of intraocular tumors
Jérry Y. Niederkorn · 2009 · Progress in Retinal and Eye Research
Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses – Pre-Clinical Evidence and Ongoing Clinical Applications
Anja Derer, Lisa Deloch, Yvonne Rubner, Rainer Fietkau, Benjamin Frey, Udo S. Gaipl · 2015 · Frontiers in Immunology
Dendritic Cells, Indoleamine 2,3 Dioxygenase and Acquired Immune Privilege
Lei Huang, Babak Baban, Burles Avner Johnson, Andrew L. Mellor · 2010 · International Reviews of Immunology
Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism
Paolo Ettore Porporato, Valéry L. Payen, Bjorn Baselet, Pierre Sonveaux · 2015 · Cellular and Molecular Life Sciences
Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia
Valentina Folgiero, Bianca Maria Goffredo, Perla Filippini, Riccardo Masetti, Giuseppina Bonanno, Roberta Caruso, Valentina Bertaina, Angela Mastronuzzi, Stefania Gaspari, Marco Zecca et al. · 2013 · Oncotarget
New Opportunities from the Cancer Metabolome
Omran Abu Aboud, Robert H. Weiss · 2012 · Clinical Chemistry
IDO inhibitors move center stage in immuno-oncology
Cormac Sheridan · 2015 · Nature Biotechnology
Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase
Antonio Curti, Michela Aluigi, Simona Pandolfi, Elisa Ferri, Alessandro Isidori, Valentina Salvestrini, Ilaria Durelli, Alberto L. Horenstein, F Fiore, Massimo Massaia et al. · 2006 · Leukemia
Cancer immunogenicity, danger signals, and DAMPs: What, when, and how?
Abhishek Dinkarnath Garg, Aleksandra M. Dudek, Patrizia Agostinis · 2013 · BioFactors
Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies
Arta Monir Monjazeb, Michael Sean Kent, Steven K. Grossenbacher, Christine Mall Minnar, Anthony Elston Zamora, Annie Mirsoian, Mingyi Chen, Amir Kol, Stephen Lawrence Shiao, Abhinav Reddy et al. · 2016 · Clinical Cancer Research
Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?
Cemil Bilir, Can Sarısözen · 2017 · Journal of Oncological Sciences
CaCO3-Assisted Preparation of pH-Responsive Immune-Modulating Nanoparticles for Augmented Chemo-Immunotherapy
Yujie Zhu, Zhijuan Yang, Ziliang Dong, Yimou Gong, Yu Hao, Longlong Tian, Xianzhu Yang, Zhuang Liu, Liangzhu Feng · 2020 · Nano-Micro Letters
IDO-expressing regulatory dendritic cells in cancer and chronic infection
Alexey Popov, Joachim Ludwig Schultze · 2007 · Journal of Molecular Medicine
Improving Antitumor Immune Responses by Circumventing Immunoregulatory Cells and Mechanisms
Gregory A. Lizee, Laszlo George Radvanyi, Willem W. Overwijk, Patrick Hwu · 2006 · Clinical Cancer Research
Regulation of Cancer Germline Antigen Gene Expression: Implications for Cancer Immunotherapy
Stacey N. Akers, Kunle O. Odunsi, Adam R. Karpf · 2010 · Future Oncology
Immunonutrition vs Standard Nutrition for Cancer Patients: A Systematic Review and Meta‐Analysis (Part 1)
Kaili Yu, Xiaoya Zheng, Guiyue Wang, Miao Liu, Yuhang Li, Pulin Yu, Mengyuan Yang, Nana Guo, Xiaohui Ma, Yue Bu et al. · 2019 · Journal of Parenteral and Enteral Nutrition
Immunobiology of Merkel Cell Carcinoma: Implications for Immunotherapy of a Polyomavirus-Associated Cancer
Shailender Bhatia, Olga K. Afanasiev, Paul Nghiem · 2011 · Current Oncology Reports
Combinatorial approach to cancer immunotherapy: strength in numbers
Anna E. Vilgelm, Douglas Buckner Johnson, Ann J. Richmond · 2016 · Journal of Leukocyte Biology
A systematic review of metabolomic profiling of gastric cancer and esophageal cancer
Sha Huang, Yang Guo, Zhexuan Li, Yang Zhang, Tong Zhou, Wei‐Cheng You, Kai‐Feng Pan, Wenqing Li · 2020 · Cancer Biology and Medicine
Polypeptide nanoformulation-induced immunogenic cell death and remission of immunosuppression for enhanced chemoimmunotherapy
Xiangru Feng, Weiguo Xu, Jianhua Liu, Di Li, Li Gao, Jianxun Ding, Xuesi Chen · 2020 · 中国科学通报：英文版
MUC1 Enhances Tumor Progression and Contributes Toward Immunosuppression in a Mouse Model of Spontaneous Pancreatic Adenocarcinoma
Teresa L. Tinder, Durai B. Subramani, Gargi Dan Basu, Judy Martina Bradley, Jorge L. Schettini, Million Arefayene, Todd C. Skaar, Pinku Mukherjee · 2008 · The Journal of Immunology
Host-pathogen interactions between the human innate immune system and Candida albicans—understanding and modeling defense and evasion strategies
Sybille Dühring, Sebastian Germerodt, Christine Skerka, Peter F. Zipfel, Thomas Dandekar, Stefan Schuster · 2015 · Frontiers in Microbiology
Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO
Anle Zhang, Yuanhong Zheng, Zujun Que, Lingling Zhang, Shengchao Lin, Vanminh Le, Jianwen Liu, Jianhui Tian · 2014 · Journal of Cancer Research and Clinical Oncology
Amino-acid sensing and degrading pathways in immune regulation
Ursula Grohmann, Giada Mondanelli, Maria Laura Belladonna, Ciriana Orabona, Maria Teresa Pallotta, Alberta Iacono, Paolo Puccetti, Claudia Volpi · 2017 · Cytokine & Growth Factor Reviews
T-cell death and cancer immune tolerance
Binfeng Lu, Olivera J. Finn · 2007 · Cell Death and Differentiation
High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome
Martine E.D. Chamuleau, Arjan A. van de Loosdrecht, Corine J. Hess, Jeroen J. W. M. Janssen, Adri Zevenbergen, R Delwel, Peter J.M. Valk, Bob Löwenberg, Gert Jan Ossenkoppele · 2008 · Haematologica
The role of IDO in brain tumor immunotherapy
Lijie Zhai, Kristen L. Lauing, Alan Lee Chang, Mahua Dey, Jun Qian, Yu Cheng, Maciej S. Lesniak, Derek Alan Wainwright · 2014 · Journal of Neuro-Oncology
miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer
Qiong Lou, Ruixian Liu, Xiangling Yang, Weiqian Li, Lan Ji Huang, Lili Wei, Huiliu Tan, Nanlin Xiang, Ka‐Wo Chan, Junxiong Chen et al. · 2019 · Journal for ImmunoTherapy of Cancer
Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors
David P. Meininger, Leeanne P. Zalameda, Yichin Liu, Lara P. Stepan, Luís Borges, John D. McCarter, Claire L. Sutherland · 2011 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Targeting Myelomonocytic Cells to Revert Inflammation-Dependent Cancer Promotion
Mario P. Colombo, Alberto Mantovani · 2005 · Cancer Research
Silencing IDO in dendritic cells: A novel approach to enhance cancer immunotherapy in a murine breast cancer model
Xiufen Zheng, James D. Koropatnick, Di Chen, Thomas J. Velenosi, Hong Ling, Xusheng Zhang, Nan Jiang, Benjamin Navarro, Thomas E. Ichim, Bradley L. Urquhart et al. · 2012 · International Journal of Cancer
Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism
Yang Li, Nan Hu, Dan Yang, Gregory F. Oxenkrug, Qing Yang · 2017 · FEBS Journal
The role of PD-1/PD-L1 axis and macrophage in the progression and treatment of cancer
Jiajing Cai, Qi Qi, Xuemeng Qian, Jia Gang. Han, Xinfang Zhu, Qi Zhang, Rong Xia · 2019 · Journal of Cancer Research and Clinical Oncology
The complex biology of aryl hydrocarbon receptor activation in cancer and beyond
Christiane A. Opitz, Pauline Holfelder, Mirja Tamara Prentzell, Saskia Trump · 2023 · Biochemical Pharmacology
T Cells and Cancer: How Metabolism Shapes Immunity
Barbara Molon, Bianca Calì, Antonella Viola · 2016 · Frontiers in Immunology
Mechanisms of Inflammation-Associated Depression: Immune Influences on Tryptophan and Phenylalanine Metabolisms
Barbara Strasser, Barbara Sperner‐Unterweger, Dietmar Fuchs, Johanna Maria Gostner · 2016 · Current topics in behavioral neurosciences
Modulation of Cancer-Specific Immune Responses by Amino Acid Degrading Enzymes
Elina Timosenko, Andreas V. Hadjinicolaou, Vincenzo Cerundolo · 2016 · Immunotherapy
A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer
Rebecca Sophie Kristeleit, Ірина Давиденко, Vadim Shirinkin, Fatima El-Khouly, Igor Bondarenko, Michael Joseph Goodheart, В. А. Горбунова, Carol A. Penning, Jack G. Shi, Xiangdong Liu et al. · 2017 · Gynecologic Oncology
Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses
Nathalie Rouas‐Freiss, Philippe Moreau, Catherine Menier, Joël LeMaoult, Edgardo Delfino Carosella · 2007 · Seminars in Cancer Biology
ONIOM Study on a Missing Piece in Our Understanding of Heme Chemistry: Bacterial Tryptophan 2,3-Dioxygenase with Dual Oxidants
Lung Wa Chung, Xin Li, Hiroshi Sugimoto, Yoshitsugu Shiro, Keiji Morokuma · 2010 · Journal of the American Chemical Society
Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients
Reinhart Speeckaert, Karim Vermaelen, Nanja van Geel, Philippe Autier, Jo Lambert, Marc Haspeslagh, Mireille Van Gele, Kris Thielemans, Bart Neyns, Nathalie A. Roche et al. · 2011 · European Journal of Cancer
Tryptophan degradation in autoimmune diseases
Christiane A. Opitz, Wolfgang Wick, Lawrence Steinman, Michael Platten · 2007 · Cellular and Molecular Life Sciences
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells
Antonio Curti, Sara Trabanelli, C. Onofri, Michela Aluigi, Valentina Salvestrini, Darina Očadlíková, Cecilia Evangelisti, Sergio Rutella, Raimondo DE CRISTOFARO, Emanuela Ottaviani et al. · 2010 · Haematologica
Inflammation Fuels Tumor Progress and Metastasis
Jingyi Liu, Pengnian Charles Lin, Binhua Peter Zhou · 2015 · Current Pharmaceutical Design
Sono/Photodynamic Nanomedicine‐Elicited Cancer Immunotherapy
Yuce Li, Jun Xie, Wooram Um, Dong Gil You, Seunglee Kwon, Lianbin Zhang, Jintao Zhu, Jae Hyung Park · 2020 · Advanced Functional Materials
Expression of Indoleamine 2,3-Dioxygenase and Correlation With Pathological Malignancy in Gliomas
Kentaro Mitsuka, Tomoyuki Kawataki, Eiji Satoh, Takayuki Asahara, Toru Horikoshi, Hiroyuki Kinouchi · 2013 · Neurosurgery
Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines
Shih Ling HWANG, Nancy P. Y. Chung, Jacqueline K. Chan, Chen-Lung Steve Lin · 2005 · Cell Research
The Desmoplastic Stroma Plays an Essential Role in the Accumulation and Modulation of Infiltrated Immune Cells in Pancreatic Adenocarcinoma
Vegard Tjomsland, Lina Niklasson, Per Sandström, Kurt Borch, Henrik Druid, Charlotte Bratthäll, Davorka Messmer, Marie Larsson, Anna Spångéus · 2011 · Clinical and Developmental Immunology
Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer
Srikanth Santhanam, David M. Alvarado, Matthew A. Ciorba · 2015 · Translational research
The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review
Luca Mazzarella, Bruno Achutti Duso, Dario Trapani, Carmen Belli, Paolo D’Amico, Emanuela Ferraro, Giulia Viale, Giuseppe Curigliano · 2019 · European Journal of Cancer
Prognostic and predictive role of tumour-associated macrophages in HER2 positive breast cancer
Tiia J. Honkanen, Antti Tikkanen, Peeter Karihtala, Markus J. Mäkinen, Juha P. Väyrynen, Jussi Pekka Koivunen · 2019 · Scientific Reports
Immune Landscape of Thyroid Cancers: New Insights
Elisa Menicali, Martina Guzzetti, Silvia Morelli, Sonia Moretti, Efisio Puxeddu · 2021 · Frontiers in Endocrinology
L-kynurenine induces NK cell loss in gastric cancer microenvironment via promoting ferroptosis
Jianxin Cui, Xian-Hui Xu, Tao He, Jia-Jia Liu, Tian-Yu Xie, Wen Tian, Jun-Yan Liu · 2023 · Journal of Experimental & Clinical Cancer Research
Expression of Indoleamine 2,3-Dioxygenase (IDO) by Endothelial Cells: Implications for the Control of Alloresponses
Sven C. Beutelspacher, Peng Tan, Myra O. McClure, Frank Larkin, Lechler Ri, Andrew J.T. George · 2006 · American Journal of Transplantation
Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions
Strasser, Barbara, Becker, Kathrin, Fuchs, Dietmar, Gostner, Johanna M. · 2017 · Neuropharmacology
Tumoral Immune Resistance Mediated by Enzymes That Degrade Tryptophan
Nicolas van Baren, Benoit J. Van den Eynde · 2015 · Cancer Immunology Research
Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
Mithunah Krishnamoorthy, Lara Gerhardt, Saman Maleki Vareki · 2021 · Cells
Metabolic interplay: tumor macrophages and regulatory T cells
Stefania Vilbois, Yingxi Xu, Ping‐Chih Ho · 2023 · Trends in cancer
Reinstalling Antitumor Immunity by Inhibiting Tumor-Derived Immunosuppressive Molecule IDO through RNA Interference
Xiufen Zheng, James D. Koropatnick, Mu Li, Xusheng Zhang, Fengjun Ling, Xiubao Ren, Xishan Hao, Hongtao Sun, Costin Vladau, Jacob A. Franek et al. · 2006 · The Journal of Immunology
Tumor Microenvironment and Immune Escape
Soldano Ferrone, Theresa L. Whiteside · 2007 · Surgical Oncology Clinics of North America
Current concepts of tumor-infiltrating lymphocytes in human malignancies
Shin‐Heng Chiou, Bor‐Ching Sheu, Wen‐Chun Chang, Su‐Cheng Huang, Hong‐Nerng Ho · 2005 · Journal of Reproductive Immunology
Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer
Miho Takao, Aikou Okamoto, Takashi Nikaido, Mitsuyoshi Urashima, Satoshi Takakura, Misato Saito, Motoaki Saito, Sanshiro Okamoto, Osamu Takikawa, Hiroshi Sasaki et al. · 2007 · Oncology Reports
Systemic Delivery of Salmonella typhimurium Transformed with IDO shRNA Enhances Intratumoral Vector Colonization and Suppresses Tumor Growth
Céline A. Blache, Edwin Ramos Manuel, Teodora I. Kaltcheva, Andrea N. Wong, Joshua D.I. Ellenhorn, Bruce R. Blazar, Don J. Diamond · 2012 · Cancer Research
Identifying and Overcoming Immune Resistance Mechanisms in the Melanoma Tumor Microenvironment
Thomas Frank Gajewski · 2006 · Clinical Cancer Research
The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma
Jeonghyun Cho, Hyo-Ji Lee, Hyun‐Jeong Ko, Byung-Il Yoon, Jongseon Choe, Keun‐Cheol Kim, Tae‐Wook Hahn, Jeong A. Han, Sun Shim Choi, Young Mee Jung et al. · 2017 · Oncotarget
High expression of indoleamine 2,3‐dioxygenase in the tumour is associated with medullary features and favourable outcome in basal‐like breast carcinoma
Jocelyne D. Jacquemier, François Bertucci, Pascal Finetti, Benjamin Esterni, Emmanuelle Charafe‐Jauffret, Marie‐Laure Thibult, Gilles F. Houvenaeghel, Benoit J. Van den Eynde, Daniel Birnbaum, Daniel Olive et al. · 2011 · International Journal of Cancer
The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation
Konstantin Knoblich, Sara Cruz Migoni, Susan Siew, Elizabeth Jinks, Baksho Kaul, Hannah C. Jeffery, Alfie T. Baker, Muath Suliman, Katerina Vrzalikova, Hisham Mehenna et al. · 2018 · PLoS Biology
Targeting indoleamine-2,3-dioxygenase in cancer: Scientific rationale and clinical evidence
Biagio Ricciuti, Giulia Costanza Leonardi, Paolo Puccetti, Francesca Fallarino, Vanessa Bianconi, Amirhossein Sahebkar, Sara Baglivo, Rita Chiari, Matteo Pirro · 2018 · Pharmacology & Therapeutics
ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer
Guru Sonpavde, Andrea Necchi, Shilpa Gupta, Gary D. Steinberg, Juergen E. Gschwend, Michiel Simon Van Der Heijden, Nathalie Garzon, Mohammed F. K. Ibrahim, Bradley Raybold, Danny Liaw et al. · 2019 · Future Oncology
Tumor Promotion by Tumor-Associated Macrophages
Porta, Chiara, Kumar, Biswas Subhra, Larghi, Paola, Rubino, Luca, Mancino, Alessandra, Sica, Antonio · 2007 · Advances In Experimental Medicine And Biology
Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients
Yunlong Jia, Hongyan Wang, Yu Wang, Tingting Wang, Miao Wang, Ming Ma, Yuqing Duan, Xianli Meng, Lihua Liu · 2015 · International Journal of Cancer
IL4i1 and IDO1: Oxidases that control a tryptophan metabolic nexus in cancer
Leonie Zeitler, Peter J. Murray · 2023 · Journal of Biological Chemistry
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy
Christina Kober, Julian Roewe, Norbert Schmees, Lars Roese, Ulrike Roehn, Benjamin Bader, Detlef Stoeckigt, Florian Prinz, Mátyás Gorjánácz, Helge Gottfried Roider et al. · 2023 · Journal for ImmunoTherapy of Cancer
Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent manners
Xinmei Zhu, B. Fallert-Junecko, Mitsugu Fujita, Ryo Ueda, Gary Kohanbash, Edward R. Kastenhuber, Heather A. McDonald, Yan Liu, Paweł Kaliński, Todd A. Reinhart et al. · 2010 · Cancer Immunology Immunotherapy
Progression of Pancreatic Adenocarcinoma Is Significantly Impeded with a Combination of Vaccine and COX-2 Inhibition
Pinku Mukherjee, Gargi Dan Basu, Teresa L. Tinder, Durai B. Subramani, Judy Martina Bradley, Million Arefayene, Todd C. Skaar, Giovanni De Petris · 2009 · The Journal of Immunology
Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival
Debbie M. Ferns, Ido P. Kema, Marrije R. Buist, Hans W. Nijman, Gemma G. Kenter, Ekaterina S. Jordanova · 2015 · OncoImmunology
Metabolic features of macrophages in inflammatory diseases and cancer
Yi Rang Na, Sungmo Je, Seung Hyeok Seok · 2017 · Cancer Letters
The application of nanotechnology in immune checkpoint blockade for cancer treatment
Huan Deng, Zhiping Zhang · 2018 · Journal of Controlled Release
Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function
Lydia Dyck, Hannah Prendeville, Mathilde Raverdeau, Mieszko M. Wilk, Róisín M. Loftus, Aaron Douglas, Janet McCormack, Bruce Moran, Michael Wilkinson, Evanna L. Mills et al. · 2022 · The Journal of Experimental Medicine
Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)–producing dendritic cells: too much ado about IDO?
Peter Terness, Jing-Jing Chuang, Thomas M. Bauer, Lucian Petru Jiga, Gerhard Opelz · 2004 · Blood
The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease
Konstantinos A. Polyzos, Daniel F.J. Ketelhuth · 2015 · Hämostaseologie
NLRC5/CITA: A Key Player in Cancer Immune Surveillance
Sayuri Yoshihama, Saptha Vijayan, Tabasum Sidiq, Koichi S. Kobayashi · 2017 · Trends in cancer
The Molecular Link from Diet to Cancer Cell Metabolism
Shree Bose, Annamarie E. Allen, Jason W. Locasale · 2020 · Molecular Cell
Immunogenic-cell-killing and immunosuppression-inhibiting nanomedicine
Ying Wang, Di Gao, Yan Liu, Xiaoqing Guo, Shuojia Chen, Li Zeng, Jinxuan Ma, Xingcai Zhang, Zhongmin Tian, Zhe Yang · 2020 · Bioactive Materials
Enzymology of mammalian NAD metabolism in health and disease
Giulio Magni · 2008 · Frontiers in bioscience
Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: Absence of toxicity due to saturating absorption
Lee Jia, Karen M. Schweikart, Joseph E. Tomaszewski, John G. Page, Patricia E. Noker, Sarah A. Buhrow, Joel M. Reid, Matthew M. Ames, David H. Munn · 2007 · Food and Chemical Toxicology
Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells
Frédéric Marteau, Nathalie Suarez Gonzalez, David Communi, Michel Goldman, Jean‐Marie Boeynaems, Didier Communi · 2005 · Blood
The immunobiology of myeloid-derived suppressor cells in cancer
Morteza Motallebnezhad, Farhad Jadidi‐Niaragh, Elmira Safaie Qamsari, Salman Bagheri, Tohid Gharibi, Mehdi Yousefi · 2015 · Tumor Biology
Clinical significance of T cell metabolic reprogramming in cancer
Christoph Herbel, Nikolaos Patsoukis, Kankana Bardhan, Pankaj Seth, Jessica D. Weaver, Vassiliki A. Boussiotis · 2016 · Clinical and Translational Medicine
IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor Activation
Adaobi E. Amobi, Ravikumar Muthuswamy, Sebastiano Battaglia, Han Yu, Tao Liu, Jianmin Wang, Vasanta Putluri, Prashant Kumar Singh, Feng Qian, Ruea-Yea Huang et al. · 2021 · Frontiers in Immunology
Solid stress impairs lymphocyte infiltration into lymph-node metastases
Dennis Jones, Zixiong Wang, Ivy X. Chen, Sue Zhang, Rohin Banerji, Pin‐Ji Lei, Hengbo Zhou, Victoria Xiao, Cecilia Kwong, Jan Willem van Wijnbergen et al. · 2021 · Nature Biomedical Engineering
Density Functional Theory Study on a Missing Piece in Understanding of Heme Chemistry: The Reaction Mechanism for Indoleamine 2,3-Dioxygenase and Tryptophan 2,3-Dioxygenase
Lung Wa Chung, Xin Li, Hiroshi Sugimoto, Yoshitsugu Shiro, Keiji Morokuma · 2008 · Journal of the American Chemical Society
Adoptive Transfer of Type 1 CTL Mediates Effective Anti–Central Nervous System Tumor Response: Critical Roles of IFN-Inducible Protein-10
Fumihiko Nishimura, Jill E. Dusak, Junichi Eguchi, Xinmei Zhu, Andrea A. Gambotto, Walter J. Storkus, Hideho Okada · 2006 · Cancer Research
Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies
Bohuslav Melichar, Dagmar Solichová, Ralph S. Freedman · 2006 · International Journal of Gynecological Cancer
Mechanisms of Intrinsic Tumor Resistance to Immunotherapy
John Markus Rieth, Subbaya Subramanian · 2018 · International Journal of Molecular Sciences
microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients
Luigi Mari, Sanne Johanna Maria Hoefnagel, Domenico Zito, Marian van de Meent, Peter Van Endert, Silvia Calpe, Maria del Carmen Sancho‐Serra, Mirjam H.M. Heemskerk, Hanneke W.M. van Laarhoven, Maarten C.C.M. Hulshof et al. · 2018 · Gastroenterology
Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
Aurélie Hanoteau, Jared M. Newton, Rosemarie Krupar, Chen Lu Huang, Hsuan‐Chen Liu, Angelina Gaspero, Robyn D. Gartrell, Yvonne M. Saenger, Thomas D. Hart, Saskia J A M Santegoets et al. · 2019 · Journal for ImmunoTherapy of Cancer